Showing results (1421-1430 of 1,437) with videos related to
Sort By:
Pageof 144
Nature Medicine|November 15, 2016
DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodelingOlga A Guryanova, Kaitlyn Shank, Barbara Spitzer, et al.Science (New York, N.Y.)|February 8, 2020
CRISPR-engineered T cells in patients with refractory cancerEdward A Stadtmauer, Joseph A Fraietta, Megan M Davis, et al.Blood Advances|August 7, 2024
Beat-AML 2024 ELN-refined risk stratification for older adults with newly diagnosed AML given lower-intensity therapyFieke W Hoff, William G Blum, Ying Huang, et al.Integrated Environmental Assessment and Management|January 28, 2017
Recommended approaches to the scientific evaluation of ecotoxicological hazards and risks of endocrine-active substancesPeter Matthiessen, Gerald T Ankley, Ronald C Biever, et al.Medrxiv : the Preprint Server for Health Sciences|December 3, 2020
Clonal hematopoiesis is associated with risk of severe Covid-19Kelly L Bolton, Youngil Koh, Michael B Foote, et al.Nature Communications|October 14, 2021
Clonal hematopoiesis is associated with risk of severe Covid-19Kelly L Bolton, Youngil Koh, Michael B Foote, et al.Science Advances|November 13, 2024
TET2 regulates early and late transitions in exhausted CD8+ T cell differentiation and limits CAR T cell functionAlexander J Dimitri, Amy E Baxter, Gregory M Chen, et al.American Journal of Hematology|July 3, 2026
Signaling Mutations Negate the Favorable Impact of NPM1 Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With VEN/HMAFieke W Hoff, Joshua F Zeidner, Geeta Torlapati, et al.Cancer Cell|August 18, 2012
Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemiaKathryn G Roberts, Ryan D Morin, Jinghui Zhang, et al.Blood|March 12, 2016
Integrated genomic DNA/RNA profiling of hematologic malignancies in the clinical settingJie He, Omar Abdel-Wahab, Michelle K Nahas, et al.Pageof 144